These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9685936)

  • 1. Image analysis studies of water transport and dimensional changes occurring in the early stages of hydration in cross-linked amylose matrices.
    Moussa IS; Lenaerts V; Cartilier LH
    J Control Release; 1998 Mar; 52(1-2):63-70. PubMed ID: 9685936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linked high amylose starch for controlled release of drugs: recent advances.
    Lenaerts V; Moussa I; Dumoulin Y; Mebsout F; Chouinard F; Szabo P; Mateescu MA; Cartilier L; Marchessault R
    J Control Release; 1998 Apr; 53(1-3):225-34. PubMed ID: 9741930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water uptake by substituted amylose tablets: experimentation and numerical simulation.
    Wang HW; Kyriacos S; Cartilier L
    Drug Dev Ind Pharm; 2010 Apr; 36(4):371-8. PubMed ID: 19702481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted amylose matrices for oral drug delivery.
    Moghadam SH; Wang HW; Saddar El-Leithy E; Chebli C; Cartilier L
    Biomed Mater; 2007 Mar; 2(1):S71-7. PubMed ID: 18458424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linked amylose tablets containing alpha-amylase: an enzymatically-controlled drug release system.
    Dumoulin Y; Cartilier LH; Mateescu MA
    J Control Release; 1999 Aug; 60(2-3):161-7. PubMed ID: 10425322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of physical parameters and lubricants on the compaction properties of granulated and non-granulated cross-linked high amylose starch.
    Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Leroux JC
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1155-62. PubMed ID: 12237529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR microscopy of hydrating hydrophilic matrix pharmaceutical tablets.
    Bowtell R; Sharp JC; Peters A; Mansfield P; Rajabi-Siahboomi AR; Davies MC; Melia CD
    Magn Reson Imaging; 1994; 12(2):361-4. PubMed ID: 8170339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
    Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
    Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of high-amylose starch tablets. 3. Initial diffusion and temperature effects.
    Thérien-Aubin H; Baille WE; Zhu XX; Marchessault RH
    Biomacromolecules; 2005; 6(6):3367-72. PubMed ID: 16283767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength.
    Mikac U; Sepe A; Kristl J; Baumgartner S
    J Control Release; 2010 Aug; 145(3):247-56. PubMed ID: 20417675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets.
    Onofre FO; Wang YJ
    Int J Pharm; 2010 Jan; 385(1-2):104-12. PubMed ID: 19879935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of geometric factors on hydration kinetics of theophylline anhydrate tablets.
    Otsuka M; Kaneniwa N; Otsuka K; Kawakami K; Umezawa O; Matsuda Y
    J Pharm Sci; 1992 Dec; 81(12):1189-93. PubMed ID: 1491338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process.
    Brouillet F; Baylac G; Cartilier L; Bataille B
    Drug Dev Ind Pharm; 2010 Jul; 36(7):795-805. PubMed ID: 20136492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchrotron X-ray microtomographic study of tablet swelling.
    Laity PR; Cameron RE
    Eur J Pharm Biopharm; 2010 Jun; 75(2):263-76. PubMed ID: 20172028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR imaging of high-amylose starch tablets. 2. Effect of tablet size.
    Malveau C; Baille WE; Zhu XX; Marchessault RH
    Biomacromolecules; 2002; 3(6):1249-54. PubMed ID: 12425662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
    Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
    Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer particle erosion controlling drug release. II. Swelling investigations to clarify the release mechanism.
    Zuleger S; Fassihi R; Lippold BC
    Int J Pharm; 2002 Oct; 247(1-2):23-37. PubMed ID: 12429482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tableting pressure on hydration kinetics of theophylline anhydrate tablets.
    Otsuka M; Kaneniwa N; Kawakami K; Umezawa O
    J Pharm Pharmacol; 1991 Apr; 43(4):226-31. PubMed ID: 1676732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.